Toll-like receptor 4 (TLR4) which acts as a receptor for lipopolysaccharide (LPS) has been reported to be involved in carcinogenesis. However, the regulatory mechanism of it has not been elucidated. Herein, we demonstrate that TLR4 promotes the malignant growth of liver cancer stem cells. Mechanistically, TLR4 promotes the expression of histone-lysine N-methyltransferase (SUV39 h2) and increases the formation of trimethyl histone H3 lysine 9-heterochromatin protein 1-telomere repeat binding factor 2 (H3K9me3-HP1-TRF2) complex at the telomeric locus under mediation by long non coding RNA urothelial cancer-associated 1 (CUDR). At the telomeric locus, this complex promotes binding of POT1, pPOT1, Exo1, pExo1, SNM1B and pSNM1B but prevents binding of CST/AAF to telomere, thus controlling telomere and maintaining telomere length. Furthermore, TLR4 enhances interaction between HP1a and DNA methyltransferase (DNMT3b), which limits RNA polymerase II deposition on the telomeric repeat-containing RNA (TERRA) promoter region and its elongation, thus inhibiting transcription of TERRA. Ultimately, TLR4 enhances the telomerase activity by reducing the interplay between telomerase reverse transcriptase catalytic subunit (TERT) and TERRA. More importantly, our results reveal that tri-complexes of HP1 isoforms (a, b and c) are required for the oncogenic action of TLR4. This study elucidates a novel protection mechanism of TLR4 in liver cancer stem cells and suggests that TLR4 can be used as a novel therapeutic target for liver cancer.
decompaction and demethylation of the proximal TLR4 promoter. 3 In addition, TLR4 signalling via NANOG cooperates with Signal Transducers and Activators of Transcription 3 (STAT3) to promote formation of tumour-initiating stem-like cells in livers. 4 It also suggests that TLR4 drives breast cancer cell growth differentially depending on the presence of tumour suppressor P53. 5 Three members of the human heterochromatin protein 1 (HP1) family (HP1a, HP1b and HP1c) are involved in chromatin packing and epigenetic gene regulation. 6 Emerging evidence has shown that HP1a plays a unique biological role in breast cancer-related processes and particularly in epigenetic control mechanisms involved in aberrant cell proliferation and metastasis. 7 a, b and c proteins of HP1 family selectively bind to methylated lysine 9 of histone H3 via their chromo-domains. Also, HP1c recognition of lysine 9 in the histone H3 tail in different nucleosome structures plays a role in reading the histone code. 8 Notably, both HP1a and Argonaute 1 (AGO1)
are involved in chromatin-related splicing regulation. 9 Moreover, HP1 regulates alternative splicing in a methylation-dependent manner by recruiting splicing factors to its methylated form. 10 Telomere length and telomerase activity normalize after several rounds of passaging, which is consistent with the ability of Pim-1
(PIM kinases, a family of Ser/Thr kinases) to transiently increase mitosis. 11 Telomere repeat binding factors 1 (TRF1) and 2 (TRF2)
binding to telomeres are modulated by nucleosomal organization. 12 The stability of mammalian telomeres depends on TRF2, which prevents inappropriate repair and checkpoint activation. 13 Upon telomere shortening or telomere uncapping induced by loss of TRF2, telomeres elicit a DNA damage response leading to cellular senescence. 14 The human telomerase RNA component (hTR) activates the DNA-dependent protein kinase to phosphorylate heterogeneous nuclear ribonucleoprotein. 15 In particular, long non coding RNA urothelial cancer-associated 1 (lncRNA CUDR) promotes liver cancer stem cell growth through up-regulating telomerase reverse transcriptase catalytic subunit (TERT) and C-Myc. 16 Long non coding telomeric repeat-containing RNA (TERRA) is involved in telomere maintenance in a telomerase-dependent and a telomerase-independent manner during replicative senescence and cancer. 17 TERRA participates in the regulation of telomere length, telomerase activity and heterochromatinization. 18 Some research shows that telomeres are protected from hyper-resection through the repression of the Ataxia-telangiectasia-mutated (ATM) and ATR kinases by TRF2 and tripeptidyl peptidase 1-bound telomeric DNA binding proteins 1a/b (TPP1-bound POT1a/b), respectively. 19 Moreover, Exo1 extensively resects both telomere ends, generating transient long 3 0 overhangs in S phase/G2 phase checkpoint. CST/AAF, a DNA pola primase accessory factor, binds POT1b and shortens the extended overhangs produced by Exo1, likely through fill-in synthesis. 20, 21 Furthermore, genetic variants in telomere maintenance genes are associated with genomic instability, cancer risk and cancer metastasis. [22] [23] [24] In this study, we attempted to elucidate TLR4 functions during the malignant growth of liver cancer stem cells. Specifically, we investigated whether TLR4 promotes the malignant proliferation and growth of liver cancer stem cells in vitro and in vivo, and investi- 
| Cell lines and plasmids
hLCSC were maintained in Dulbecco's modified Eagle's medium (Gibco BRL Life Technologies) supplemented with 10% heat-inactivated foetal bovine serum (Gibco BRL Life Technologies) in a humidified atmosphere of 5% CO 2 at 37°C. pCMV6-AC-GFP and pGFP-V-RS were purchased from OriGene (Rockville, MD, USA). pcDNA3.1-DNMT3b, pcDNA3.1-HP1a, pcDNA3.1-HP1b, pcDNA3.1-HP1c were purchased from Addgene (Cambridge MA, USA). pCMV6-AC-GFP-TLR4, pGFP-V-RS-TLR4, pGFP-V-RS-HP1a, pGFP-V-RS-HP1b, pGFP-V-RS-HP1c were prepared in our laboratory.
| Co-immunoprecipitation (IP)
Co-immunoprecipitation was carried out according to methodology as previously described. 25 Briefly, cell lysates were incubated with 2 lg antibody or normal mouse/rabbit IgG under rotation for 4 hours at 4°C. Then, the immunoprecipitates were incubated with 30 lL protein G/A-plus agarose beads under rotation overnight at 4°C. The precipitates were washed with beads solution for five times, and then, the precipitates were resuspended in 60 lL 2 9 SDS-PAGE sample loading buffer. Western blotting was then performed.
| Chromatin immunoprecipitation (ChIP) assay
Chromatin immunoprecipitation was carried out according to methodology as previously described. 26 Briefly, cells were crosslinked with 1% (v/v) formaldehyde (Sigma-Aldrich) for 10 minutes at ZHENG ET AL.
| 3247 room temperature. Chromatin extracts were immunoprecipitated with specific antibody on protein-A/G-sepharose beads. After washing and de-cross-linking, the ChIP DNA was detected by PCR. 3 | RESULTS
| Quantitative telomerase detection

| Xenograft transplantation in vivo
| TLR4 promotes malignant proliferation of hLCSCs in vitro
We used CD133/CD44/CD24/EpCAM MicroBeads to isolate hLCSCs from human liver cancer cell line Huh7 by detecting the markers of hLCSCs, including CD133, CD44, CD24 and EpCAM. As shown in Figure 1Aa , CD133, CD44, CD24 and EpCAM were expressed in hLCSCs. However, these were not expressed in nonhLCSCs. We detected the expression of TLR4, MD2 and CD14 in non-transfected hLCSCs and non-hLCSCs by Western blotting. The results showed that the expression of TLR4 in hLCSCs was significantly higher than that in non-hLCSCs, and the expression of MD2 or CD14 in hLCSCs was lower than that in non-hLCSCs ( Figure S1 ).
Then, we established four stable hLCSC lines transfected with pCMV6-AC-GFP (GFP ctrl group), pCMV6-AC-GFP-TLR4 (TLR4 group), pGFP-V-RS (RNAi ctrl group) and pGFP-V-RS-TLR4 (TLR4i group), respectively. As shown in Figure 1Ab , compared with GFP ctrl group, TLR4 expression was significantly enhanced in TLR4
group. However, TLR4 expression was significantly reduced in TLR4i group compared with RNAi ctrl group. Furthermore, the expression of TLR4 on cell surface was significantly increased in TLR4 overexpressing hLCSC and was significantly decreased in TLR4 knockeddown hLCSC compared to control ( Figure S2 ).
As shown in Figure 1B , compared with growth of hLCSCs in GFP ctrl group (P < .01), that in TLR4 group was significantly increased; however, compared with growth of hLCSCs in RNAi ctrl group, that in TLR4i group was significantly decreased. In addition, compared with soft-agar colony formation of hLCSCs in GFP ctrl group (P < .01), that in TLR4 group was significantly increased; however, compared with soft-agar colony formation of hLCSCs in RNAi ctrl group (P < .01), that in TLR4i group was significantly decreased ( Figure 1C ). Furthermore, compared with the proportion of BrdUpositive cells in GFP ctrl group, that in TLR4 group was significantly increased; however, compared with the proportion of BrdU-positive cells in RNAi ctrl group (P < .01), that in TLR4i group was significantly decreased ( Figure 1D ). Strikingly, sphere formation rate of hLCSCs was significantly higher in TLR4 group than in the GFP ctrl group (P < .01), whereas that was lower in TLR4i group than in the RNAi ctrl group (P < .01) ( Figure 1E ). Moreover, our results showed that excessive TLR4 significantly increased the interaction between TLR4 and MD2 (a TLR4 ligand) or TLR4 and MyD88 (a TLR4 dimer ligand) ( Figure S3A Figure S3B ). These results suggest that TLR4 promotes the proliferation of liver cancer stem cells in vitro.
| TLR4 accelerates growth of hLCSCs in vivo
To further explore the effect of TLR4 on hLCSCs in vivo, the four stable hLCSCs lines were injected subcutaneously into athymic BALB/c mice, respectively. As shown in Figure 2A , ). E, PCNA-positive cell analysis of xenograft tumours. Each value was presented as mean AE standard error of the mean (SEM). mean AE SEM. **P < .01; *P < .05. For all Western blotting, we repeated the experiments for three times. We measured grey value of the bands for quantification. Each value was presented as mean AE standard error of the mean (SEM) (Student's t test).
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| 3249 appeared later in TLR4i group than in RNAi ctrl group (P < .01) (Figure 2C) . Furthermore, xenograft tumour differentiation was poorer in TLR4 group than in GFP ctrl group, whereas that was better in TLR4i group than in RNAi ctrl group ( Figure 2D , upper pictures).
Strikingly, the percentage of proliferating cell nuclear antigen (PCNA)-positive cells from xenograft tumours was significantly higher in TLR4 group than in GFP ctrl group (P < .01), whereas that was significantly lower in TLR4i group than in RNAi ctrl group (P < .01) ( Figure 2D , lower pictures; Figure 2E ). These results demonstrate that TLR4 accelerates malignant growth of liver cancer stem cells in vivo.
| TLR4 enhances the interplay between HP1 isoforms and H3K9me3
To investigate the possible mechanism of action of TLR4, we first studied whether TLR4 influenced histone H3 modification in hLCSCs. We analysed the NF-kB responsive element (5 0 -AGTT GAGGGGACTTTCCCAGGC-3 0 ) in all the promoters investigated in this study and only found that two NF-kB-responsive elements is in CUDR promoter region. As shown in Figure 3A , TLR4 overexpression enhanced the binding of NF-jB to the non coding RNA CUDR promoter region. As shown in Figure S4 , the luciferase activity of F I G U R E 3 TLR4 increases interplay between HP1 isoforms and H3K9me3 via CUDR. A, Chromatin Immunoprecipitation (ChIP) with anti-NF-jB followed by PCR with CUDR promoter primers. IgG ChIP served as negative control. B, RT-PCR analysis of CUDR mRNA. b-Actin served as internal control. C, RNA Immunoprecipitation (RIP) with anti-SUV39 h1 followed by RT-PCR with CUDR promoter primers. IgG RIP served as the negative control. D, Co-immunoprecipitation (Co-IP) with anti-SUV39 h2 followed by Western blotting with antihistone. IgG IP served as the negative control. Western blotting with anti-SUV39 h2 served as INPUT. E, Co-IP with anti-SUV39 h2 followed by Western blotting with antihistone H3. IgG IP served as negative control. Western blotting with anti-SUV39 h2 served as INPUT. F, Western blotting with anti-HP1a, anti-HP1b, anti-HP1c, anti-H3K9me3, anti-SUV39 h2. b-Actin served as an internal control. G, Western blotting with antiH3K9me3 (four hLCSC lines with CUDR being depleted). b-Actin was the internal control. H, Co-IP with anti-H3K9me3 followed by Western blotting with anti-HP1a, anti-HP1b and anti-HP1c. IgG IP served as negative control. Western blotting with anti-HP1a, anti-HP1b, anti-HP1c served as INPUT. I, Co-IP with anti-H3K9me3 followed by Western blotting with anti-HP1a. IgG IP was used as negative control. Western blotting with anti-HP1a as INPUT. Each value was presented as mean AE standard error of the mean (SEM). Mean AE SEM. **P < .01; *P < .05. For all Western blotting, we repeated the experiments for three times. We measured grey value of the bands for quantification. Each value was presented as mean AE standard error of the mean (SEM) (Student's t test)
CUDR promoter in hLCSCs was higher in TLR4 group than in GFP ctrl group, whereas that was lower in TLR4i group than in RNAi ctrl group. As shown in Figure 3B , compared with GFP ctrl group, TLR4
group enhanced CUDR expression in hLCSCs; however, compared with RNAi ctrl group, TLR4i group decreased that. As shown in Fig- ure 3C,D, compared with GFP ctrl group, TLR4 group enhanced interplay between histone-lysine N-methyltransferase (SUV39 h2) and CUDR and interplay between SUV39 h2 and histone H3; however, compared with RNAi ctrl group, TLR4i group decreased those.
CUDR knockdown can fully abrogate the action of excessive TLR4 involved in enhancing interplay between SUV39 h2 and histone H3
( Figure 3E ). In addition, as shown in Figure 3F , compared with GFP ctrl group, TLR4 group increased formation of trimethyl histone H3 lysine 9 (H3K9me3); however, compared with RNAi ctrl group, TLR4i
group . Bar AE SEM. **P < .01; *P < .05. For all Western blotting, we repeated the experiments for three times. We measured grey value of the bands for quantification. Each value was presented as mean AE standard error of the mean (SEM) (Student's t test)
3.4 | TLR4 controls telomere length through
H3K9me3
Given that TLR4 increases formation of H3k9me3, we studied whether TLR4 can alter telomere length via H3K9me3. As shown in Figure 4A , compared with GFP ctrl group, TLR4 group increased interplays between the telomere DNA probe and HP1a, HP1b, HP1c, TRF2, H3K9me3; however, compared with RNAi ctrl group, TLR4i group decreased those. As shown in Figure 4B , compared with GFP ctrl group, TLR4 group increased loadings of HP1a, HP1b, HP1c, TRF2 and H3K9me3 onto the telomere DNA; however, compared with RNAi ctrl group, TLR4i group decreased those. As shown in Figure 4C , compared with GFP ctrl group, TLR4 group increased interplays between the telomere DNA probe and pTOP1, TOP1, pExo1, Exo1, pSNM1b, NM1b, but decreased interplay between CST/AAF and the telomere DNA probe; however, compared with RNAi ctrl group, TLR4i group decreased interplays between the telomere DNA probe and pTOP1, TOP1, pExo1, Exo1, pSNM1b, SNM1b, but increased interplay between CST/AAF and the telomere DNA probe. As shown in Figure 4D ,E, compared with GFP ctrl group, TLR4 group increased telomere length; however, compared with RNAi ctrl group, TLR4i group decreased telomere length. It should be noticed that when H3K9me3 was demethylated by pCMV6-AC-GFP-JMJD2A (a demethylase that demethylates trimethyl histone H3 lysine 9) (Figure 4Fa ), the action of TLR4 to alter telomere length was fully abrogated (Figure 4Fb ). These results suggest that TLR4 increases telomere length depending on H3K9me3.
| TLR4 increases telomerase activity through
HP1a-DNMT3b pathway
To study whether activation of HP1a-H3K9me3 pathway helps TLR4 alter activity of telomerase involved in DNA methyltransferase (DNMT3b), we first analysed the interrelation between HP1a and DNMT3b in hLCSCs. As shown in Figure 5A , there was an interplay between HP1a and DNMT3b in hLCSCs.
Moreover, the formation of HP1a-DNMT3b complex reduced the interplay between DNMT3b and telomere DNA (lncRNA TERRA promoter) in hLCSCs ( Figure 5B ). In addition, HP1a inhibited the DNMT3b activity and reduced the methylation on lncRNA TERRA promoter region ( Figure 5C,D) . However, these actions were fully abrogated when TLR4 was knocked down ( Figure 5C ). Furthermore, the excessive DNMT3b increased the methylation on lncRNA TERRA promoter region. However, these actions were fully abrogated when TLR4 was knocked down ( Figure S5 ). Moreover, TLR4 knockdown increases the interaction between HP1a
and DNMT3b ( Figure S6 ). It suggests that TLR4 knockdown inhibits the activity of DNMT3b through increasing the interaction between HP1a and DNMT3b. Thus, TLR4 knockdown seems to block the activity of DNMT3b by enhancing the interplay between HP1a and DNMT3b.
Given that HP1a inhibited DNMT3b activity and reduced methylation on TERRA promoter region, which is associated with TLR4, we studied whether TLR4 could alter telomerase activity. As shown in Fig . mean AE SEM. **P < .01; *P < .05. For all Western blotting, we repeated the experiments for three times.
We measured grey value of the bands for quantification. Each value was presented as mean AE standard error of the mean (SEM) (Student's t test) knockdown can alter the expression of TERC ( Figure 6B ). Moreover, compared with GFP ctrl group, TLR4 group increased interplay between TERT and TERC, but decreased interplay between TERT and TERRA; however, compared with RNAi ctrl group, TLR4i group decreased interplay between TERT and TERC, but increased interplay between TERT and TERRA ( Figure 6C ). Finally, compared with GFP ctrl group, TLR4 group increased telomerase activity in hLCSCs; however, compared with RNAi ctrl group, TLR4i group decreased that (Figure 6D) . These results suggest that TLR4 increases telomerase activity via HP1a-DNMT3b pathway. , and TLR4i group transfected with pcDNA-(HP1a, HP1b and HP1c). Each value was presented as mean AE standard error of the mean (SEM). Mean AE SEM. **P < .01; *P < .05. For all Western blotting, we repeated the experiments for three times. We measured grey value of the bands for quantification. Each value was presented as mean AE standard error of the mean (SEM) (Student's t test)
3.6 | HP1 isoforms (HP1a, HP1b and HP1c) are required for TLR4 oncogenic action
Given that TLR4 enhances the interplay between HP1 isoforms (HP1a, HP1b and HP1c), increases the telomere length by HP1-H3K9me3 and increases telomerase activity by HP1-DNMT3b pathway, we studied whether HP1 (HP1a, HP1b and HP1c) could determine the TLR4 oncogenic function. To analyse the formation of tricomplex of HP1a-HP1b-HP1c, we performed the repeat co-immunoprecipitation (IP) experiments, that is, first, HP1a IP and second, HP1b repeat IP with the immunoprecipitates from HP1a IP.
As shown in Figure 7A ,B, TLR4 overexpression increased interaction among HP1a, HP1b and HP1c in hLCSCs, whereas TLR4 knockdown decreased that. As shown in Figure S7 , we show the specificity of each knockdown reagent (HP1a, HP1b and HP1c).
The expression of HP1a was significantly reduced only in HP1a knockdown group, the expression of HP1b was significantly reduced only in HP1b knockdown group, and the expression of HP1c was significantly reduced only in HP1c knockdown group.
Strikingly, TLR4 overexpression increased loadings of TRF2, POT1, Exo1 and SNM1b on telomere DNA in hLCSCs, whereas TLR4 knockdown decreased those ( Figure 7C ). TLR4 overexpression increased loading of H3K9me3 and HP1a on telomere DNA, loading of DNMT3b on TERRA promoter region and interaction between TERT and TERC in hLCSCs, whereas TLR4 knockdown decreased those ( Figure 7D ). Furthermore, TLR4 overexpression led to increase in telomerase activity and telomere length; however, these actions were fully abrogated by depletion of HP1a, HP1b, been reported to play a significant role in various cancers. However, the regulatory mechanism of TLR4 has not been elucidated. To our knowledge, this study might be the first to demonstrate that TLR4 controls telomeres through HP1 isoforms in hLCSCs. As shown in Figure 8 , we provide evidence that TLR4 promotes the malignant proliferation and growth of hLCSCs in vitro and in vivo. Strikingly, our results also reveal that tri-complexes of HP1 isoforms (a, b and c) are required for TLR4 oncogenic action. The detailed discussion is as follows.
First, accumulating evidence indicates that TLR4 might stimulate carcinoma initiation and progression. 27, 28 Our present results are consistent with these reports and provide novel evidence for an active role of TLR4 in promoting liver cancer stem cell growth. This evidence is based on results from two parallel sets of experiments:
(i) TLR4 facilitates proliferation of hLCSCs in vitro, and (ii) TLR4
accelerates growth of hLCSCs in vivo.
In addition, epigenetic engineering shows that a human centromere can resist silencing, which is mediated by H3K27me3/ K9me3. 29 Suppressor of variegation 3-9 homologue 2 (SUV39 h2) is a SET domain-containing histone methyltransferase that is up-regulated in solid cancers, 30 which inhibits polyubiquitination in human cancer cells by methylating and stabilizing LSD1. 31 Our results suggest that Furthermore, accumulating evidence suggests that the human TERT contributes to cell physiology independently of its ability to elongate telomeres, 34 and the shelterin protein TRF2 is essential for chromosome-end protection. 35 Our previous findings suggest that SET1A plus CUDR increased TRF2 expression at the transcriptional and translational level and its activity through H3K4me3. 36 Particularly, TERRA RNA interacts with several telomere-associated proteins, including TRF1 and TRF2. 37 Our results also show that TLR4 enhances telomerase activity. This is based on several results of hLCSCs: (i) HP1a inhibits activity of DNMT3b that alters methylation of TERRA promoter by forming the HP1a-DNMT3b complexes, (ii) TLR4 inhibits TERRA expression by decreasing the HP1a-DNMT3b complexes, and (iii) TLR4 increases telomerase activity through increasing interaction between TERT and TREC but decreasing the interaction between TERT and TERRA.
Also, some studies show that HP1 mediates the recognition and destruction of heterochromatic RNA transcripts 38 and promotes tumour suppressor BRCA1 functions during the DNA damage response. 39 Strikingly, heterochromatic-silencing factors preclude histone turnover to promote silencing and inheritance of repressive chromatin. 40 Particularly, HP1a nucleates with high affinity independently of H3K9me in promoters of active genes and then spreads via H3K9 methylation and transient looping contacts with those H3K9me target sites. 41 
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